Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Liver Diseases and Immunity, and Hepatitis C virus research.
Implementation of a care bundle improves PBC management
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis
Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin‐α
New metrics for the Lancet Standing Commission on Liver Disease in the UK
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis